Publications:

Long-term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD-L1 expression.

Molecular And Clinical Oncology

Sakai, Hitomi H; Takeda, Masayuki M; Sakai, Kazuko K; Nishio, Kazuto K; Nakagawa, Kazuhiko K

Publication Date: 2020-08

Variant appearance in text: BRAF: S37Y

PubMed Link: 32714542

Variant Present in the following documents:

• Main text

View BVdb publication page

Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.

Acta Neuropathologica Communications

Hölsken, Annett A; Sill, Martin M; Merkle, Jessica J; Schweizer, Leonille L; Buchfelder, Michael M; Flitsch, Jörg J; Fahlbusch, Rudolf R; Metzler, Markus M; Kool, Marcel M; Pfister, Stefan M SM; von Deimling, Andreas A; Capper, David D; Jones, David T W DT; Buslei, Rolf R

Publication Date: 2016-02-29

Variant appearance in text: BRAF: S37Y

PubMed Link: 26927026

Variant Present in the following documents:

• Main text
• 40478_2016_Article_287.pdf

View BVdb publication page

ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.

Oncotarget

Hutchinson, Katherine E KE; Johnson, Douglas B DB; Johnson, Adam S AS; Sanchez, Violeta V; Kuba, Maria M; Lu, Pengcheng P; Chen, Xi X; Kelley, Mark C MC; Wang, Qingguo Q; Zhao, Zhongming Z; Kris, Mark M; Berger, Michael F MF; Sosman, Jeffrey A JA; Pao, William W

Publication Date: 2015-09-08

Variant appearance in text: BRAF: S37Y

PubMed Link: 26084293

Variant Present in the following documents:

• oncotarget-06-22348-s002.xlsx, sheet 2
• oncotarget-06-22348-s002.xlsx, sheet 1

View BVdb publication page